טוען...
Immunotherapy in Chronic Lymphocytic Leukaemia (CLL)
Chronic lymphocytic leukaemia (CLL) is well known to generate impaired immune responses in the host, with the malignant clone residing in well-vascularized tissues and circulating in peripheral blood but also in close proximity to effector cells that are capable, if activated appropriately, of elici...
שמור ב:
| הוצא לאור ב: | Curr Hematol Malig Rep |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer US
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4796351/ https://ncbi.nlm.nih.gov/pubmed/26857283 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11899-015-0295-9 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|